We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
PREMAS Biotech Launches its Range of Human Drug Metabolism Enzymes
Product News

PREMAS Biotech Launches its Range of Human Drug Metabolism Enzymes

PREMAS Biotech Launches its Range of Human Drug Metabolism Enzymes
Product News

PREMAS Biotech Launches its Range of Human Drug Metabolism Enzymes


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "PREMAS Biotech Launches its Range of Human Drug Metabolism Enzymes"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

PREMAS Biotech launches its suite of recombinant Human Cytochrome P450 Isozymes expressed in Saccharomyces cerevisiae. These Microsomes contain human CYP450 isozyme and human NADPH oxido reductase hence offering higher specific activity and performance.

These Isozymes will be expressed in Yeast which means that these recombinant human enzymes mimic their native forms and Ensures biological and pharmacologically active isoforms. PREMAS will be using their Proprietary vectors for optimized expression.
Advertisement